Aytu Bioscience (AYTU) Hits New 1-Year Low at $1.00

Aytu Bioscience Inc (NASDAQ:AYTU)’s share price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $1.00 and last traded at $1.06, with a volume of 2311 shares traded. The stock had previously closed at $1.11.

Separately, Northland Securities assumed coverage on Aytu Bioscience in a report on Monday, October 22nd. They issued an “outperform” rating and a $10.00 target price for the company.

The firm has a market capitalization of $2.00 million, a PE ratio of -0.03 and a beta of 6.25.

COPYRIGHT VIOLATION NOTICE: This news story was posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://www.thelincolnianonline.com/2018/11/10/aytu-bioscience-aytu-hits-new-1-year-low-at-1-00.html.

Aytu Bioscience Company Profile (NASDAQ:AYTU)

Aytu BioScience, Inc, a specialty healthcare company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and ZolpiMist, an oral spray for the treatment of insomnia.

Read More: How analysts view the yield curve

Receive News & Ratings for Aytu Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aytu Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply